Open AccessERYTHRODERMA AND ANTITUBERCULOUS THERAPY: CLINICAL CASE
Author(s) -
Denis V. Zaslavsky,
S.S. Yakushenko Yakushenko,
Марина Андреевна Королева,
И. Н. Чупров,
A. S. Sidikov
Publication year - 2017
Publication title -
rossijskij žurnal kožnyh i veneričeskih boleznej
Language(s) - English
Resource type - Journals
eISSN - 2412-9097
pISSN - 1560-9588
DOI - 10.18821/1560-9588-2017-20-6-342-346
Subject(s) - erythroderma , medicine , dermatology , disease , pathology
Erythroderma represents one of the most complex problems of dermatology. First of all, it is explained by variety of reasons, a pathogenesis ambiguity, monotonous clinical picture, tendency of many forms of an erythroderma to a long and heavy current and resistance to therapy. The erythroderma doesn’t represent a certain disease, it is, most likely, clinical implication of set of various diseases. The majority of erythroderma cases described in literature have been induced by different types of medicines and dietary supplements. In English-speaking literature more than ten cases of erythroderma induced from various components of anti-tuberculous therapy are described. The first case of eryhtroderma in Russian-speaking scientific literature which appeared in five months from the beginning of anti-tuberculous therapy is presented.